In recent trading session, Petros Pharmaceuticals Inc (NASDAQ:PTPI) saw 1.1 million shares changing hands at last check today with its beta currently measuring 2.09. Company’s recent per share price level of $0.07 trading at $0.0 or -5.42% at last check today assigns it a market valuation of $3.64M. That most recent trading price of PTPI’s stock is at a discount of -1371.43% from its 52-week high price of $1.03 and is indicating a premium of 28.57% from its 52-week low price of $0.05. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 179.11 million shares which gives us an average trading volume of 36.16 million if we extend that period to 3-months.

Petros Pharmaceuticals Inc (NASDAQ:PTPI) trade information

Upright in the red during last session for losing -5.42%, in the last five days PTPI remained trading in the red while hitting it’s week-highest on Tuesday, 04/01/25 when the stock touched $0.07 price level, adding 36.01% to its value on the day. Petros Pharmaceuticals Inc’s shares saw a change of -82.71% in year-to-date performance and have moved -38.65% in past 5-day. Petros Pharmaceuticals Inc (NASDAQ:PTPI) showed a performance of -24.33% in past 30-days. Number of shares sold short was 0.75 million shares which calculate 0.04 days to cover the short interests.

Petros Pharmaceuticals Inc (NASDAQ:PTPI)’s Major holders

Insiders are in possession of 6.01% of company’s total shares while institution are holding 4.86 percent of that, with stock having share float percentage of 5.17%. Investors also watch the number of corporate investors in a company very closely, which is 4.86% institutions for Petros Pharmaceuticals Inc that are currently holding shares of the company.

On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Jan 31, 2025, the former fund manager was holding 34.65 shares of worth $2362.0 or 0.12% of the total outstanding shares. The later fund manager was in possession of 31.81 shares on Dec 31, 2024, making its stake of worth around $2169.0 in the company or a holder of 0.11% of company’s stock.